Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Plus Therapeutics Inc (PSTV)

3   0.08 (2.74%) 08-07 14:57
Open: 3.56 Pre. Close: 2.92
High: 3.54 Low: 2.78
Volume: 4,405,149 Market Cap: 12M
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and manufacture of treatments for cancer and other diseases. Its lead product candidate is DocePLUS, a protein-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer. The company is also involved in developing DoxoPLUS, a generic PEGylated liposomal encapsulated doxorubicin to treat breast and ovarian cancer, multiple myeloma, and Kaposi's sarcoma. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.042 - 3.057 3.057 - 3.07
Low: 2.518 - 2.532 2.532 - 2.546
Close: 2.894 - 2.919 2.919 - 2.943

Technical analysis

as of: 2020-08-07 2:29:38 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.16     One year: 4.86
Support: Support1: 2.63    Support2: 2.06
Resistance: Resistance1: 3.56    Resistance2: 4.16
Pivot: 2.59
Moving Average: MA(5): 2.77     MA(20): 2.49
MA(100): 1.92     MA(250): 3.07
MACD: MACD(12,26): 0.17     Signal(9): 0.14
Stochastic oscillator: %K(14,3): 71.84     %D(3): 70.98
RSI: RSI(14): 67.57
52-week: High: 22.89  Low: 0.93  Change(%): -46.8
Average Vol(K): 3-Month: 41755  10-Days: 83326

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PSTV has closed below upper band by 5.3%. Bollinger Bands are 20.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 07 Aug 2020
Plus Therapeutics, Inc. (PSTV) Sitting On The Launchpad, Waiting For The Long Term Buyers - Stocks Register

Fri, 07 Aug 2020
Is Plus Therapeutics Inc (PSTV) Stock About to Get Hot Friday? - InvestorsObserver

Fri, 07 Aug 2020
54 Stocks Moving in Friday's Pre-Market Session - Benzinga

Thu, 06 Aug 2020
What is Forecast Price for Plus Therapeutics Inc (PSTV) Stock? - InvestorsObserver

Wed, 05 Aug 2020
Plus Therapeutics Inc. (NASDAQ:PSTV) Reports a Successful Completion of the fifth Cohort of the ReSPECT Clinical Trial and Expansion to a Second Clinical Trial Site - BP Journal

Mon, 03 Aug 2020
Plus Therapeutics To Report Second Quarter Fiscal Year 2020 Financial Results And Corporate Update on August 10, 2020 - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 4
Shares Float (M) 4
% Held by Insiders 0.74
% Held by Institutions 18.84
Shares Short (K) 146
Shares Short P. Month (K) 53

Stock Financials

EPS -30.616
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.060
Profit Margin -138.33
Operating Margin -61.64
Return on Assets (ttm) -10.8
Return on Equity (ttm) -96.7
Qtrly Rev. Growth -84.0
Gross Profit (p.s.) 0.397
Sales Per Share 1.552
EBITDA (p.s.) -0.854
Qtrly Earnings Growth
Operating Cash Flow (M) -4
Levered Free Cash Flow (M) 2

Stock Valuations

PE Ratio -0.10
PEG Ratio
Price to Book value 49.67
Price to Sales 1.92
Price to Cash Flow -2.96

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.